Meals and snacks with “GLP-1 Friendly” labels are appearing more often in U.S. supermarkets in 2024 and 2025. This change is linked to the growing use of weight-loss drugs such as Wegovy and Zepbound. These medicines copy a hormone that reduces appetite and changes digestion, so users often eat smaller meals. A report by the Kaiser Family Foundation said about 12 percent of U.S. adults were using GLP-1 drugs by late 2024 for weight loss or diabetes care. Food companies have started selling meals made for smaller portions. However, the label is not regulated by the U.S. Food and Drug Administration and does not mean medical approval.

Health experts say food quality is more important than labels. Because hunger is lower, meals should include enough protein, fiber, and fluids. Dietitians recommend around 20 to 30 grams of protein per meal and regular fiber intake. Some packaged foods are suitable, but shoppers should read nutrition labels carefully. Products from Nestlé and Conagra show how food companies are responding. Experts say prepared meals may help with planning, but good health depends on balanced eating and guidance from professionals.